共 176 条
[31]
Barrera V(2005)Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 692-155
[32]
de Miguel G(2001)Oral Anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range Chest 119 8S-49
[33]
Jiménez-García R(2016)Adequate time in therapeutic INR range using triple antithrombotic therapy is not associated with long-term cardiovascular events and major bleeding complications after drug-eluting stent implantation J Cardiol 68 517-636
[34]
Sudlow C(1993)A Method to determine the optimal intensity of oral anticoagulant therapy Thromb Haemost 69 236-554
[35]
Rodgers H(2009)Measuring Quality of Oral Anticoagulation care: extending quality measurement to a new field Jt Comm J Qual Patient Saf 35 146-142
[36]
Kenny R(2016)Advantages of a warfarin protocol for long-term care pharmacists: a retrospective cohort study Can Geriatr J 19 40-1086
[37]
Thomson R(2008)Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review BMC Geriatr 8 13-974
[38]
Taylor F(2005)Impact of adherence, knowledge, and quality of life on anticoagulation control Ann Pharmacother 39 632-235
[39]
Ramsay M(2009)Constant use of oral anticoagulants: implications in the control of their adequate levels Arq Bras Cardiol 93 549-445
[40]
Renton A(2011)INR Goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a veterans affairs medical center J Manag Care Pharm 17 133-482